Back to mobile site

Xenon Pharmaceuticals (XENE) PT Raised to $8 at Jefferies Following New Epilepsy Asset

May 10, 2017 10:35 AM EDT Send to a Friend
Jefferies raised its price target on Xenon Pharmaceuticals (NASDAQ: XENE) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login